Publicaciones
-
Shah, SD, Mathes, EF, Baselga E, Frieden, IJ, Powell, J, Garzon, MC, Morel, KD, Lauren, CT, Mancini, AJ, Chamlin, SL, Rios, M, Belmesk, L and McCuaig, CC.
Multicenter retrospective review of pulsed dye laser in nonulcerated infantile hemangioma
PEDIATRIC DERMATOLOGY . 40(1): 28-34. Nº de citas: 3
-
Ghaffarpour N, Baselga E, Boon LM, Diociaiuti A, Dompmartin A, Dvorakova V, El Hachem M, Gasparella P, Haxhija E, Kyrklund K, Irvine AD, Kapp FG, Rößler J, Salminen P, van den Bosch C, van der Vleuten C, Kool LS and Vikkula M.
The VASCERN-VASCA working group diagnostic and management pathways for lymphatic malformations
EUROPEAN JOURNAL OF MEDICAL GENETICS . 65(12): 104637-104637. Nº de citas: 13
-
Kittler NW, Frieden IJ, Abuabara K, Siegel DH, Horii KA, Mathes EF, Blei F, Haggstrom AN, Streicher JL, Metry DW, Garzon MC, Morel KD, Lauren CT, Hogeling M, Fernandez Faith E and Baselga E.
Successful use of telemedicine for evaluation of infantile hemangiomas during the early COVID-19 pandemic: A cross-sectional study
PEDIATRIC DERMATOLOGY . 39(5): 718-726. Nº de citas: 3
-
Kobialka P, Sabata H, Vilalta O, Gouveia L, Angulo-Urarte A, Muixí L, Zanoncello J, Muñoz-Aznar O, Gene-Olaciregui N, Fanlo L, Esteve-Codina A, Lavarino C, Javierre BM, Celis-Passini V, Rovira-Zurriaga C, López-Fernández S, Baselga E, Mora J, CastilloSD and Graupera M.
The onset of PI3K-related vascular malformations occurs during angiogenesis and is prevented by the AKT inhibitor miransertib
EMBO Molecular Medicine . 14(7): . Nº de citas: 37
-
Diociaiuti A, Baselga E, Boon LM, Dompmartin A, Dvorakova V, El Hachem M, Gasparella P, Haxhija E, Ghaffarpour N, Kyrklund K, Irvine AD, Kapp FG, Rößler J, Salminen P, van den Bosch C, van der Vleuten C, Kool LS and Vikkula M.
The VASCERN-VASCA working group diagnostic and management pathways for severe and/or rare infantile hemangiomas
EUROPEAN JOURNAL OF MEDICAL GENETICS . 65(6): 104517-104517. Nº de citas: 3
-
Wollenberg, A, Marcoux, D, Silverberg, JI, Aoki, V, Baselga E, Zhang, HX, Levit, NA, Taieb, A and Rossi, AB.
Dupilumab Provides Rapid and Sustained Improvement in SCORing Atopic Dermatitis Outcomes in Paediatric Patients with Atopic Dermatitis
ACTA DERMATO-VENEREOLOGICA . 102: . Nº de citas: 5
-
Carrascosa Carrillo JM, Baselga E, Gilaberte Calzada Y, Jurgens Martínez YN, Roustan Gullón G, Yanguas Bayona JI, Gómez Castro S, Ferrario MG and Rebollo Laserna FJ.
Quantifying Physician Preferences for Systemic Atopic Dermatitis Treatments Using a Discrete-Choice Experiment
Dermatology and Therapy . 12(5): 1197-1210. Nº de citas: 8
-
Iznardo H, Bredrup C, Bernal S, Gladkauskas T, Mascaró JM Jr, Roé E and Baselga E.
Clinical and molecular response to dasatinib in an adult patient with Penttinen syndrome
AMERICAN JOURNAL OF MEDICAL GENETICS PART A . 188(4): 1233-1238. Nº de citas: 6
-
Douzgou S, Rawson M, Baselga E, Danielpour M, Faivre L, Kashanian A, Keppler-Noreuil KM, Kuentz P, Mancini GMS, Maniere MC, Martinez-Glez V, Parker VE, Semple RK, Srivastava S, Vabres P, de Wit MY, Graham JM Jr, Clayton-Smith J, Mirzaa GM and Biesecker LG.
A standard of care for individuals with PIK3CA-related disorders: An international expert consensus statement
CLINICAL GENETICS . 101(1): 32-47. Nº de citas: 32
-
Baselga E, El Hachem M, Diociaiuti A, Carnevale C, Downey C, Roe E, Mascaro P, Neri I, Leuzzi M, Bernabeu-Wittel J, Monserrat-García MT, Ortiz-Prieto A, Torrelo A, Knopfel N, Vercellino N, Manunza F, Oranges T, Bassi A, González-Enseñat MA, Vicente-Villa MA, Gich I and Puig L.
Sequelae following infantile haemangiomas treated with propranolol
EUROPEAN JOURNAL OF DERMATOLOGY . 31(6): 785-790. Nº de citas: 6